SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-23-008988
Filing Date
2023-12-05
Accepted
2023-12-05 16:25:58
Documents
14
Period of Report
2023-12-01
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ipix_8k.htm   iXBRL 8-K 18946
  Complete submission text file 0001477932-23-008988.txt   131778

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ipix-20231201.xsd EX-101.SCH 5735
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20231201_lab.xml EX-101.LAB 13171
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20231201_cal.xml EX-101.CAL 908
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20231201_pre.xml EX-101.PRE 8259
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20231201_def.xml EX-101.DEF 2109
8 EXTRACTED XBRL INSTANCE DOCUMENT ipix_8k_htm.xml XML 3291
Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880
Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37357 | Film No.: 231466943
SIC: 2834 Pharmaceutical Preparations